{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:33:03Z","timestamp":1772515983318,"version":"3.50.1"},"reference-count":45,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2022,2,28]]},"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:p>In this article, we provide a historical view of key aspects of British Cardiovascular Society (BCS) influence in clinical trials of ischaemic heart disease (IHD) followed by key research and developments, notable publications and future perspectives. We discuss the role of the BCS and its members. The scope of this article covers clinical trials in stable IHD and acute coronary syndromes, including interventions relating to diagnosis, treatment and management. We discuss the role of the BCS in supporting the original RITA trials. We highlight the changing face of angina and its management providing contemporary and future insights into microvascular disease, ischaemic symptoms with no obstructive coronary arteries and, relatedly, myocardial infarction with no obstructive coronary arteries. The article is presented as a brief overview of the BCS in IHD research, relationships with stakeholders, patient and public involvement and clinical trials from the perspective of past, present and future possibilities.<\/jats:p>","DOI":"10.1136\/heartjnl-2021-320150","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T16:02:36Z","timestamp":1651161756000},"page":"800-806","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["The British Cardiovascular Society and clinical studies in ischaemic heart disease: from RITA to ORBITA, and beyond"],"prefix":"10.1136","volume":"108","author":[{"given":"Rasha","family":"Al-Lamee","sequence":"first","affiliation":[{"name":"Cardiology, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Aubiniere-Robb","sequence":"additional","affiliation":[{"name":"BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-8636","authenticated-orcid":false,"given":"Colin","family":"Berry","sequence":"additional","affiliation":[{"name":"BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK"},{"name":"Cardiology, Golden Jubilee National Hospital, Clydebank, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"2025101713311234000_108.10.800.1","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0140-6736(01)50093-8","article-title":"The clinical aspects of isch\u00e6mic necrosis of the heart muscle","volume":"206","author":"Gibson","year":"1925","journal-title":"The Lancet"},{"key":"2025101713311234000_108.10.800.2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.24.6.673"},{"key":"2025101713311234000_108.10.800.3","doi-asserted-by":"publisher","DOI":"10.1177\/003693306300801102"},{"key":"2025101713311234000_108.10.800.4","doi-asserted-by":"publisher","DOI":"10.1177\/003693306300801202"},{"key":"2025101713311234000_108.10.800.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.8.2013"},{"key":"2025101713311234000_108.10.800.6","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.56.6.501"},{"key":"2025101713311234000_108.10.800.7","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.38.7.659"},{"key":"2025101713311234000_108.10.800.8","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.45.1.88"},{"key":"2025101713311234000_108.10.800.9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(88)92833-4","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2","volume":"332","year":"1988","journal-title":"The Lancet"},{"key":"2025101713311234000_108.10.800.10","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.62.5.411"},{"key":"2025101713311234000_108.10.800.11","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90348-K"},{"key":"2025101713311234000_108.10.800.12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0140-6736(94)92274-8","article-title":"Health service costs of coronary angioplasty and coronary artery bypass surgery: the randomised intervention treatment of angina (RITA) trial","volume":"344","author":"Sculpher","year":"1994","journal-title":"The Lancet"},{"key":"2025101713311234000_108.10.800.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03358-3"},{"key":"2025101713311234000_108.10.800.14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(97)07298-X","article-title":"Coronary angioplasty versus medical therapy for angina: the second randomised intervention treatment of angina (RITA-2) trial","volume":"350","year":"1997","journal-title":"The Lancet"},{"key":"2025101713311234000_108.10.800.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00951-3"},{"key":"2025101713311234000_108.10.800.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09894-X"},{"key":"2025101713311234000_108.10.800.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67222-4"},{"key":"2025101713311234000_108.10.800.18","article-title":"Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era","volume":"2016","author":"Fanning","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025101713311234000_108.10.800.19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa575"},{"key":"2025101713311234000_108.10.800.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050849"},{"key":"2025101713311234000_108.10.800.21","unstructured":"National Institute for Health and Clinical Excellence . Acute coronary syndromes NICE guideline. NG185. National Institute for Health and Clinical Excellence, 2020."},{"key":"2025101713311234000_108.10.800.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301092"},{"key":"2025101713311234000_108.10.800.23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2025101713311234000_108.10.800.24","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2009.190827"},{"key":"2025101713311234000_108.10.800.25","unstructured":"National Institute for Health and Clinical Excellence . High-sensitivity troponin tests for the early rule out of NSTEMI. In: National Institute for health and clinical excellence. DG40, 2020."},{"key":"2025101713311234000_108.10.800.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807611"},{"key":"2025101713311234000_108.10.800.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.11.003"},{"key":"2025101713311234000_108.10.800.28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy394"},{"key":"2025101713311234000_108.10.800.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805971"},{"key":"2025101713311234000_108.10.800.30","unstructured":"National Institute for Health and Clinical Excellence . Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardaic origin (update). In: National Institute for health and clinical excellence. CG95, 2016."},{"key":"2025101713311234000_108.10.800.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904327"},{"key":"2025101713311234000_108.10.800.32","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"Complete revascularization with multivessel PCI for myocardial infarction","volume":"381","author":"Mehta","year":"2019","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025101713311234000_108.10.800.33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.338"},{"key":"2025101713311234000_108.10.800.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31923-8"},{"key":"2025101713311234000_108.10.800.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072366"},{"key":"2025101713311234000_108.10.800.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307095"},{"key":"2025101713311234000_108.10.800.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508419"},{"key":"2025101713311234000_108.10.800.38","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","article-title":"Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease","volume":"374","year":"2016","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025101713311234000_108.10.800.39","doi-asserted-by":"crossref","DOI":"10.1177\/20420188211058323","article-title":"Novel therapeutic targets and agents for pediatric dyslipidemia","volume":"12","author":"Sunil","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2025101713311234000_108.10.800.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32714-9"},{"key":"2025101713311234000_108.10.800.41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1190"},{"key":"2025101713311234000_108.10.800.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.01.024"},{"key":"2025101713311234000_108.10.800.43","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"2025101713311234000_108.10.800.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"2025101713311234000_108.10.800.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.006"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2021-320150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:31:20Z","timestamp":1760733080000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2021-320150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,4,22]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1136\/heartjnl-2021-320150"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2021-320150","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,22]]}}}